ACTIVE_NOT_RECRUITING

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.

Official Title

Determination and Validation of Lung EpiCheck®: A Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study

Quick Facts

Study Start:2021-09-17
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT04968548

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Radha Duttagupta, PhD
STUDY_DIRECTOR
Nucleix Ltd.

Study Locations (Sites)

Scripps Memorial Hospital
Encinitas, California, 92024
United States
Centura Health
Lakewood, Colorado, 80228
United States
VA Connecticut Healthcare System
West Haven, Connecticut, 06516
United States
Orlando Health, Inc.
Orlando, Florida, 32806
United States
Sarasota Memorial Hospital
Sarasota, Florida, 34239
United States
St. Elizabeth Edgewood Hospital
Edgewood, Kentucky, 41017
United States
Norton Cancer Institute
Louisville, Kentucky, 40202
United States
Owensboro Health
Owensboro, Kentucky, 42303
United States
Johns Hopkins Medical Center
Baltimore, Maryland, 21287
United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, 01805
United States
University of Minnesota Health
Minneapolis, Minnesota, 55455
United States
Harry S. Truman Memorial Veterans' Hospital
Columbia, Missouri, 65201
United States
Washington University in St. Louis
St Louis, Missouri, 63110
United States
Northwell Health
New Hyde Park, New York, 11040
United States
University of Rochester
Rochester, New York, 14627
United States
The University of North Carolina
Chapel Hill, North Carolina, 27599
United States
Duke University
Durham, North Carolina, 27705
United States
Durham VA Health Care System
Durham, North Carolina, 27710
United States
W.G. (Bill) Hefner VA Medical Center
Salisbury, North Carolina, 28144
United States
Novant Health Cancer Research
Winston-Salem, North Carolina, 27103
United States
Summa Health
Akron, Ohio, 44304
United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44106
United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
United States
Ralph H. Johnson VA Medical Center
Charleston, South Carolina, 29401
United States
Medical University of South Carolina (MUSC)
Charleston, South Carolina, 29425
United States
Baptist Cancer Center
Memphis, Tennessee, 38120
United States
Michael E. DeBakey VA Medical Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: Nucleix Ltd.

  • Radha Duttagupta, PhD, STUDY_DIRECTOR, Nucleix Ltd.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-17
Study Completion Date2025-12

Study Record Updates

Study Start Date2021-09-17
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • LDCT
  • Low Dose CT
  • Lung Cancer Screening
  • liquid biopsy
  • early detection
  • lung cancer

Additional Relevant MeSH Terms

  • Lung Cancer